For research use only. Not for therapeutic Use.
Tidutamab (Anti-CD3 & SSTR2) is a humanized and affinity-optimized bispecific antibody (bsAb) targeting SSTR2 binding domain and T-cell binding domain (CD3). It can be used in neuroendocrine tumors (NETs) and small cell lung cancer (SCLC). MW :147.36 KD.
| Catalog Number | I047491 |
| Purity | ≥95% |
| Reference | [1] Lee SH, et al. Cancer Res (2017) 77 (13_Supplement): 3633. |
